Mixed-model QSAR at the human mineralocorticoid receptor: Predicting binding mode and affinity of anabolic steroids

Toxicology Letters

Volumn 189, Issue 3, 2009, Pages 219-224

  Peristera, Ourania ^a   Spreafico, Morena ^a   Smiesko, Martin ^a   Ernst, Beat ^a   Vedani, Angelo ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Anabolic steroids; Endocrine disruption; Human mineralocorticoid receptor; Multi dimensional QSAR; VirtualToxLab

Indexed keywords

ANABOLIC AGENT; MINERALOCORTICOID RECEPTOR;

ARTICLE; BINDING AFFINITY; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENDOCRINE SYSTEM; GENETIC ALGORITHM; MATHEMATICAL MODEL; MOLECULAR DOCKING; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR BINDING; SCREENING TEST;

ALGORITHMS; ANABOLIC AGENTS; COMPUTER SIMULATION; HUMANS; HYDROGEN BONDING; LIGANDS; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, MINERALOCORTICOID; STEROIDS;

RAPTORES;

EID: 67650047727     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.05.025     Document Type: Article

References (27)

1. Arriza J.L., Weinberger C., Cerreli G., Glaser T.M., Handelin B.L., Housman D.E., and Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 (1987) 268-275
2. Bledsoe R.K., Madauss K.P., Holt J.A., Apolito C.J., Lambert M.H., Pearce K.H., Stanley T.B., Stewart E.L., Trump R.P., Willson T.M., and Williams S.P. A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J. Biol. Chem. 280 (2005) 31283-31293
3. Damstra, T., Barlow, S., Bergman, A., Kavlock, R., Van der Kraak, G., 2002. Global assessment of the state-of-the-science of endocrine disruptors. International Program on Chemical Safety, WHO, pp. 1-133.
4. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1998) 889-895
5. Fiebeler A., and Luft F. The mineralocorticoid receptor and oxidative stress. Heart Fail. Rev. 10 (2005) 47-52
6. Friedel A., Geyer H., Kamber M., Laudenbach-Leschowsky U., Schänzer W., Thevis M., Vollmer G., Zierau O., and Diet P. Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucorticoid signaling in liver. Toxicol. Lett. 164 (2006) 16-23
7. Fuller P.J. The steroid receptor superfamily: mechanisms of diversity. FASEB J. 5 (1991) 3092-3099
8. Grassy G., Fagart J., Calas B., Adenot M., Rafestin-Oblin M.E., and Autou G. Structure-activity relationships of steroids with mineralocorticoid activity. Eur. J. Med. Chem. 32 (1997) 869-879
9. Lill M.A., Vedani A., and Dobler M. Combining dual-shell representation, induced-fit simulation and hydrophobicity scoring in receptor modeling: application towards the simulation of structurally diverse ligand sets. J. Med. Chem. 47 (2004) 6174-6186
10. Mohamadi F., Richards N.G.J., Guida W.C., Liskamp R., Lipton M., Caufield C., Chang G., Heendrickson T., and Still W.C. MacroModel an integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J. Comput. Chem. 13 (1990) 356-367
11. Neel D.A., Brown M.L., Lander P.A., Grese T.A., Defauw J.M., Doti R.A., Fileds T., Kelley S.A., Smith S., Zimmerman K.M., Steinberg M.I., and Jadhar P.K. 3,3-Bisaryloxindoles as mineralocorticoid receptor antagonist. Bioorg. Med. Chem. Lett. 15 (2005) 2553-2557
12. Pascual-Le Tallec L., and Lombès M. The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol. Endocrinol. 19 (2005) 2211-2221
13. Quinkler M., Meyer B., Bumke-Vogt C., Grossmann C., Gruber U., Oelkers W., Diederich S., and Bähr V. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur. J. Endocrinol. 146 (2002) 789-800
14. Rogers D., and Hopfinger A.J. Genetic function approximation to generate a family of QSAR equations using genetic algorithms. J. Chem. Inf. Comput. Sci. 34 (1994) 854-866
15. Rogerson F.M., and Fuller P.J. Mineralocorticoid action. Steroids 65 (2000) 61-73
16. Storer J.W., Giesen D.J., Cramer C.J., and Truhlar D.G. Class IV charge models: a new semiempirical approach in quantum chemistry. J. Comput. Aided Mol. Des. 9 (1995) 87-110
17. Vedani A., and Huhta D.W. A new force field for modeling metalloproteins. J. Am. Chem. Soc. 122 (1990) 4759-4767
18. Vedani A., and Huhta D.W. An algorithm for the systematic solvation of proteins based on the directionality of hydrogen bonds. J. Am. Chem. Soc. 113 (1991) 5860-5862
19. Vedani A., and Dobler M. 5D-QSAR: the key for simulating induced fit?. J. Med. Chem. 45 (2002) 2139-2149
20. Vedani A., and Dobler M. Multidimensional QSAR: moving from three to five-dimensional concepts. Quant. Struct.-Act. Relat. 21 (2002) 382-390
21. Vedani A., Dobler M., Dollinger H., Hasselbach K.M., Birke F., and Lill M.A. Novel ligands for the chemokine receptor-3 (CCR3): a receptor-modeling study based on 5D-QSAR. J. Med. Chem. 48 (2005) 1515-1527
22. Vedani A., Dobler M., and Lill M.A. Combining protein-modeling and 6D-QSAR-simulating the binding of structural diverse ligands to the estrogen receptor. J. Med. Chem. 48 (2005) 3700-3703
23. Vedani A., Dobler M., Spreafico M., Peristera O., and Smiesko M. VirtualToxLab-in silico prediction of the toxic potential of drugs and environmental chemicals: evaluation status and Internet access protocol. ALTEX 24 (2007) 153-161
24. Vedani A., Spreafico M., Peristera O., Dobler M., and Smiesko M. VirtualToxLab-in silico prediction of endocrine-disrupting potential of drugs and chemicals. Chimia 5 (2008) 322-328
25. Weatherman R.V., Fletterick R.J., and Scanlan T.S. Nuclear-receptor ligands and ligand-binding domains. Annu. Rev. Biochem. 68 (1999) 559-581
26. Weber K.T. Aldosterone in congestive heart failure. N. Engl. J. Med. 345 (2001) 1689-1697
27. Weiner S.J., Kollmann P.A., Case D.A., Singh U.C., Ghio C., Alagona G., Profeta Jr. S., and Weiner P.A. A new force field for molecular-mechanical simulations of nucleic acids and proteins. J. Am. Chem. Soc. 106 (1984) 765-784